Elekta delivers 3D Brain Mapping Technology to leading German brain research center

The University Hospital at Heinrich-Heine-University (HHU, Düsseldorf, Germany) has installed Elekta Neuromag®, a device for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology. Completely non-invasive and painless, MEG is a powerful tool used for studying normal brain function, as well as brain disorders, such as epilepsy and autism.

Afghanistan — Wednesday, May 27, 2009

Düsseldorf, Germany, May 28, 2009

The University has been utilizing MEG technology for more than 12 years; however, recently upgraded their Elekta system, allowing researchers to record human brain activity better and more accurately than before.

“After successfully using the ‘old’ 122-channel Neuromag MEG system for more than 12 years, I’m extremely excited about the installation of the technologically-advanced 306-channel system,” says Professor Alfons Schnitzler, M.D., Ph.D., Head, Institute of Clinical Neuroscience and Medical Psychology and Director, Center for Movement Disorders and Neuromodulation, Heinrich-Heine-University.

Researchers from various departments, such as neurology, clinical neuroscience, neurosurgery, psychiatry, and experimental psychology will employ MEG to track brain activity related to sensory, motor, cognitive and emotional functions, at high temporal and spatial resolution, in healthy human subjects, as well as patients with neurological and psychiatric disorders.

“One particular focus,” says Prof. Schnitzler, “will be on the identification and modulation of oscillatory networks involved in normal brain function and their alterations in movement disorders and other neuropsychiatric diseases.”

Prof. Schnitzler also notes that the Center for Movement Disorders and Neuromodulation at HHU runs a comprehensive program on Deep Brain Stimulation (DBS). DBS delivers a constant, low electrical stimulation to the brain through implanted electrodes and is used to help partially restore normal movements in Parkinson's Disease, tremor syndromes, dystonia and other movement disorders.

“The new MEG system will allow us to record brain activity from patients with implanted DBS devices and to study mechanisms of DBS and other neuromodulatory interventions,” continues Schnitzler. “In addition to MEG, state-of-the-art MRI, PET, high-density EEG, and stereotactic TMS facilities, as well as intracranial recordings are available to complement the picture obtained from MEG measurements. This combination will provide a unique, non-invasive window through the human skull, offering exciting perspectives for clinical and cognitive neuroscientists and clinicians.”

About Elekta